Oaktree Acquisition Corp. III Life Sciences
OACCW- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.65M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Oaktree Acquisition Corp. III Life Sciences as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +11 vs. Q4 2024
- Shares held
- 2.34M
- +1.19M (+103.1%) vs. Q4 2024
- Total value
- $1.74M
- +$795.0K (+84.4%) vs. Q4 2024
- New holders
- 11
- 3 more added
- Sold out
- 0
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OACCW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $2.65M |
| Q1 2026 | 27 | $2.07M |
| Q4 2025 | 30 | $2.09M |
| Q3 2025 | 28 | $2.19M |
| Q2 2025 | 27 | $2.34M |
| Q1 2025 | 23 | $1.74M |
| Q4 2024 | 12 | $941.9K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Oaktree Acquisition Corp. III Life Sciences; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CNH Partners LLC | 396,057 | $297.0K | 0.01% | +10.0% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 340,000 | $255.0K | 0.00% | +340,000 | New |
| Decagon Asset Management LLP | 181,442 | $136.1K | 0.12% | −544−0.3% | Reduced |
| Walleye Capital LLC | 169,738 | $127.3K | 0.00% | +54,122+46.8% | Added |
| Driehaus Capital Management LLC | 180,000 | $122.4K | 0.00% | +180,000 | New |
| Boussard & Gavaudan Investment Management LLP | 150,000 | $114.0K | 0.02% | +150,000 | New |
| Shaolin Capital Management LLC | 115,000 | $86.3K | 0.00% | −19,000−14.2% | Reduced |
| Linden Advisors LP | 120,000 | $85.8K | 0.00% | +120,000 | New |
| LMR Partners LLP | 95,000 | $71.3K | 0.00% | +95,000 | New |
| Hudson Bay Capital Management LP | 90,000 | $67.5K | 0.00% | +90,000 | New |
| Periscope Capital Inc. | 90,000 | $67.5K | 0.04% | +90,000 | New |
| Gritstone Asset Management LLC | 79,726 | $59.8K | 0.06% | −273−0.3% | Reduced |
| ExodusPoint Capital Management, LP | 60,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 60,000 | $45.0K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 50,000 | $35.8K | 0.00% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 39,058 | $29.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 31,030 | $23.3K | 0.00% | +31,030 | New |
| Verition Fund Management LLC | 28,330 | $21.2K | 0.00% | −5,720−16.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 23,211 | $17.4K | 0.00% | +23,211 | New |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 16,336 | $12.3K | 0.00% | +16,336 | New |
| Picton Mahoney Asset Management | 15,000 | $11.0K | 0.00% | +15,000 | New |
| Clear Street LLC | 8,876 | $6.66K | 0.00% | +7,947+855.4% | Added |
| Highbridge Capital Management LLC | – | $75 | 0.00% | – | – |